Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19


Favourable outcome of AIDS-related multi-centric central nervous system Epstein-Barr virus-associated smooth muscle tumour with surgery and adjuvant radiation therapy: a case study and literature review.

Wujanto C, Vasoo S, Nandini CL, Nolan CP, Ng V, Wong LC.

Int J STD AIDS. 2019 May;30(6):605-609. doi: 10.1177/0956462418821569. Epub 2019 Feb 4.


Depression screening in HIV-positive Tanzanian adults: comparing the PHQ-2, PHQ-9 and WHO-5 questionnaires.

Nolan CP, O'Donnell PJM, Desderius BM, Mzombwe M, McNairy ML, Peck RN, Kingery JR.

Glob Ment Health (Camb). 2018 Nov 19;5:e38. doi: 10.1017/gmh.2018.31. eCollection 2018.


Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.

Grommes C, Tang SS, Wolfe J, Kaley TJ, Daras M, Pentsova EI, Piotrowski AF, Stone J, Lin A, Nolan CP, Manne M, Codega P, Campos C, Viale A, Thomas AA, Berger MF, Hatzoglou V, Reiner AS, Panageas KS, DeAngelis LM, Mellinghoff IK.

Blood. 2019 Jan 31;133(5):436-445. doi: 10.1182/blood-2018-09-875732. Epub 2018 Dec 19.


Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Grommes C, Pastore A, Palaskas N, Tang SS, Campos C, Schartz D, Codega P, Nichol D, Clark O, Hsieh WY, Rohle D, Rosenblum M, Viale A, Tabar VS, Brennan CW, Gavrilovic IT, Kaley TJ, Nolan CP, Omuro A, Pentsova E, Thomas AA, Tsyvkin E, Noy A, Palomba ML, Hamlin P, Sauter CS, Moskowitz CH, Wolfe J, Dogan A, Won M, Glass J, Peak S, Lallana EC, Hatzoglou V, Reiner AS, Gutin PH, Huse JT, Panageas KS, Graeber TG, Schultz N, DeAngelis LM, Mellinghoff IK.

Cancer Discov. 2017 Sep;7(9):1018-1029. doi: 10.1158/2159-8290.CD-17-0613. Epub 2017 Jun 15.


Bevacizumab in high-grade glioma patients following intraparenchymal hemorrhage.

Lin X, Daras M, Pentsova E, Nolan CP, Gavrilovic IT, DeAngelis LM, Kaley TJ.

Neurooncol Pract. 2017 Mar;4(1):24-28. doi: 10.1093/nop/npw008. Epub 2016 Dec 9.


Disseminated extracranial metastatic meningioma.

Chua FH, Low SY, Tham CK, Ding C, Wong CF, Nolan CP.

J Clin Neurosci. 2016 Nov;33:214-216. doi: 10.1016/j.jocn.2016.01.038. Epub 2016 Aug 8.


Single-Session Multilevel "Central Stentoplasty".

Pua U, Quek LH, Lim GH, Nolan CP.

J Vasc Interv Radiol. 2016 Mar;27(3):416-7. doi: 10.1016/j.jvir.2015.10.018. No abstract available.


Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma.

de la Fuente MI, Young RJ, Rubel J, Rosenblum M, Tisnado J, Briggs S, Arevalo-Perez J, Cross JR, Campos C, Straley K, Zhu D, Dong C, Thomas A, Omuro AA, Nolan CP, Pentsova E, Kaley TJ, Oh JH, Noeske R, Maher E, Choi C, Gutin PH, Holodny AI, Yen K, DeAngelis LM, Mellinghoff IK, Thakur SB.

Neuro Oncol. 2016 Feb;18(2):283-90. doi: 10.1093/neuonc/nov307. Epub 2015 Dec 20.


A review of the use of fiducial markers for image-guided bladder radiotherapy.

Nolan CP, Forde EJ.

Acta Oncol. 2016 May;55(5):533-8. doi: 10.3109/0284186X.2015.1110250. Epub 2015 Nov 20. Review.


Neurologic complications of chemotherapy and radiation therapy.

Nolan CP, DeAngelis LM.

Continuum (Minneap Minn). 2015 Apr;21(2 Neuro-oncology):429-51. doi: 10.1212/01.CON.0000464179.81957.51. Review.


Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

Kaley TJ, Wen P, Schiff D, Ligon K, Haidar S, Karimi S, Lassman AB, Nolan CP, DeAngelis LM, Gavrilovic I, Norden A, Drappatz J, Lee EQ, Purow B, Plotkin SR, Batchelor T, Abrey LE, Omuro A.

Neuro Oncol. 2015 Jan;17(1):116-21. doi: 10.1093/neuonc/nou148. Epub 2014 Aug 6.


Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.

Omuro A, Chan TA, Abrey LE, Khasraw M, Reiner AS, Kaley TJ, Deangelis LM, Lassman AB, Nolan CP, Gavrilovic IT, Hormigo A, Salvant C, Heguy A, Kaufman A, Huse JT, Panageas KS, Hottinger AF, Mellinghoff I.

Neuro Oncol. 2013 Feb;15(2):242-50. doi: 10.1093/neuonc/nos295. Epub 2012 Dec 14.


Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer.

De Braganca KC, Janjigian YY, Azzoli CG, Kris MG, Pietanza MC, Nolan CP, Omuro AM, Holodny AI, Lassman AB.

J Neurooncol. 2010 Dec;100(3):443-7. doi: 10.1007/s11060-010-0200-2. Epub 2010 May 4.


Myelopathies in patients with cancer.

Graber JJ, Nolan CP.

Arch Neurol. 2010 Mar;67(3):298-304. doi: 10.1001/archneurol.2010.20. Review.


Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma.

Clarke JL, Iwamoto FM, Sul J, Panageas K, Lassman AB, DeAngelis LM, Hormigo A, Nolan CP, Gavrilovic I, Karimi S, Abrey LE.

J Clin Oncol. 2009 Aug 10;27(23):3861-7. doi: 10.1200/JCO.2008.20.7944. Epub 2009 Jun 8.


A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.

Iwamoto FM, Omuro AM, Raizer JJ, Nolan CP, Hormigo A, Lassman AB, Gavrilovic IT, Abrey LE.

J Neurooncol. 2008 Mar;87(1):85-90. Epub 2007 Nov 7.


Evidence-based cerebral vasospasm management.

Weyer GW, Nolan CP, Macdonald RL.

Neurosurg Focus. 2006 Sep 15;21(3):E8. Review.


Leptomeningeal metastases from leukemias and lymphomas.

Nolan CP, Abrey LE.

Cancer Treat Res. 2005;125:53-69. Review.


Supplemental Content

Loading ...
Support Center